Lark, A.L.

methylation patient cancer status recurrence prostate pitx 2 methylation gleason analysis prostate cancer tumor signi study prognostic prostatectomy predictor sample margin methylation status stage signi ficantly ficant antigen margin status result gleason sum c-index marker fication signi ficant predictor measurement gleason 7 tumors survival center prognostic information identi fication speci treatment bisul fite group preoperative psa signi ficant identi information parameter biomarker outcome ͻ0.001 ficantly surgery breast therapy factor disease paraf fin baylor college review board approval prostate cancer patients figure tumor cell nuclei methylation group pitx 2 formalin fi xed table epigenomics ag preoperative bcr risk multivariate method durham veterans affairs clinicopathological parameters breast cancer .14 model subgroups value adjuvant clinicopathological regression pathology metastasi